LEGAL PROCEEDINGS - Intellectual Property (Details)						1 Months Ended			3 Months Ended
	May 04, 2023 defendant	Jul. 21, 2022	Feb. 02, 2022	Sep. 10, 2021	Mar. 26, 2020	Jan. 31, 2023	Apr. 30, 2021	Mar. 31, 2021 defendant proceeding	Mar. 31, 2023 defendant lawsuit
Norwich Pharmaceuticals Inc. Litigation
Loss Contingencies [Line Items]
Stay of approval, period					30 months
Taro Pharmaceuticals Inc. Litigation
Loss Contingencies [Line Items]
Stay of approval, period		30 months
MSN Laboratories Private Ltd. Litigation
Loss Contingencies [Line Items]
Stay of approval, period							30 months
Aurobindo Pharma Limited Litigation
Loss Contingencies [Line Items]
Stay of approval, period						30 months
PreserVision® AREDS Patent Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants								19
Number of proceedings | proceeding								16
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants									12
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants									2
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb | Subsequent Event
Loss Contingencies [Line Items]
Number of defendants	2
Lumify Paragraph I V Proceedings Slayback ANDA Litigation
Loss Contingencies [Line Items]
Stay of approval, period				30 months
Lumify Paragraph I V Proceedings Lupin ANDA Litigation
Loss Contingencies [Line Items]
Stay of approval, period			30 months
Apotex Inc. Litigation | Canada | Pending Litigation
Loss Contingencies [Line Items]
Number of lawsuits pending | lawsuit									3